| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
111,688 |
83,548 |
$8.85M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
160,479 |
141,074 |
$5.70M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
58,578 |
52,734 |
$3.29M |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
112,077 |
87,605 |
$2.57M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
33,577 |
28,969 |
$1.69M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
12,645 |
10,055 |
$732K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
24,309 |
16,226 |
$710K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
14,294 |
12,720 |
$519K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
35,369 |
29,317 |
$334K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
17,112 |
7,732 |
$172K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,277 |
1,097 |
$107K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,563 |
3,249 |
$78K |
| 81025 |
|
14,227 |
12,166 |
$66K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,506 |
3,425 |
$42K |
| 87807 |
|
4,540 |
3,412 |
$37K |
| 81003 |
|
22,178 |
17,076 |
$24K |
| 99201 |
|
1,186 |
957 |
$22K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,564 |
1,244 |
$12K |
| 71046 |
Radiologic examination, chest; 2 views |
466 |
407 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
799 |
543 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
318 |
188 |
$789.95 |
| 86308 |
|
307 |
224 |
$766.47 |
| 71045 |
Radiologic examination, chest; single view |
15 |
15 |
$173.07 |
| 93000 |
|
12 |
12 |
$142.43 |
| 94760 |
|
1,131 |
662 |
$124.09 |
| 82962 |
|
37 |
29 |
$65.04 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
358 |
306 |
$53.28 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
711 |
456 |
$42.16 |
| 87210 |
|
12 |
12 |
$33.92 |
| A6449 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard |
14 |
12 |
$3.36 |
| 99000 |
|
16,055 |
9,926 |
$2.89 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
220 |
152 |
$0.24 |
| 90662 |
|
321 |
288 |
$0.00 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
26 |
14 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
25 |
12 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
78 |
55 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
341 |
316 |
$0.00 |
| 90686 |
|
15 |
15 |
$0.00 |